Tyrosine Kinase Inhibitors
4 clinical trials · Condition
◉ Watch Tyrosine Kinase Inhibitors
| Record | Firm | Date |
|---|---|---|
| Treatment With Olverembatinib in CML-CP Patients Who Failed to at Least Two Previously Administered Second-generation TKIs. (NCT05311943) | Shenzhen Second People's Hospital | 2022-07-01 |
| CECT Features of MVI Predict Response to TACE Plus TKI in Intermediate-stage HCC (NCT07449065) | First Affiliated Hospital, Sun Yat-Sen University | 2018-06-01 |
Track Tyrosine Kinase Inhibitors automatically
Every clearance here is in the API, with alerts when new ones post.